Biosolution Co.Ltd (086820) — Financial Flexibility Index
Biosolution Co.Ltd (086820) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of ₩39.56 Million (operating CF ₩17.41 Million minus capex ₩22.15 Million) represents 0% of total liabilities (₩36.25 Billion). Also explore Biosolution Co.Ltd (086820) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biosolution Co.Ltd Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Biosolution Co.Ltd across 10 annual periods. Check Biosolution Co.Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Biosolution Co.Ltd (2015–2024)
Year-by-year free cash flow to debt coverage for Biosolution Co.Ltd. For the full company profile including market capitalisation, see 086820 company net worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.03x | ₩-1.06 Billion | ₩-2.29 Billion | ₩36.21 Billion | ▼ -144.2% |
| 2023 | 0.07x | ₩3.32 Billion | ₩2.16 Billion | ₩50.22 Billion | ▲ +1069.9% |
| 2022 | 0.01x | ₩270.90 Million | ₩-3.81 Billion | ₩47.96 Billion | ▼ -62.6% |
| 2021 | 0.02x | ₩746.44 Million | ₩83.29 Million | ₩49.39 Billion | ▲ +116.0% |
| 2020 | -0.09x | ₩-295.41 Million | ₩-1.69 Billion | ₩3.13 Billion | ▲ +18.1% |
| 2019 | -0.12x | ₩-427.10 Million | ₩-2.61 Billion | ₩3.71 Billion | ▼ -125.2% |
| 2018 | 0.46x | ₩1.73 Billion | ₩1.03 Billion | ₩3.80 Billion | ▲ +1135.9% |
| 2017 | 0.04x | ₩109.24 Million | ₩-78.53 Million | ₩2.96 Billion | ▲ +110.7% |
| 2016 | -0.34x | ₩-927.01 Million | ₩-2.07 Billion | ₩2.70 Billion | ▲ +44.2% |
| 2015 | -0.62x | ₩-1.47 Billion | ₩-2.02 Billion | ₩2.40 Billion | — |